Deep Venous Thrombosis

  • Fahad S. Alasfar
  • Dwayne Badgett
  • Anthony J. Comerota
Chapter

References

  1. 1.
    Kistner RL, Ball JJ, Nordyke RA, Freeman GC. Incidence of pulmonary embolism in the course of thrombophlebitis. Am J Surg. 1972;124:169–76.CrossRefPubMedGoogle Scholar
  2. 2.
    Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopaedic, and urologic surgery. N Engl J Med. 1988;318:1162–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Masuda EM, Kessler DM, Kistner RL, Eklof B, Sato DT. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg. 1998;28:67–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Lechner K, Pabinger-Fasching I. Lupus anticoagulant and thrombosis: a study of 25 cases and review of the literature. Haemostasis. 1985;15:254–62.PubMedGoogle Scholar
  5. 5.
    Baker WH, Potthoff WP, Biller J, McCoyd K. Carotid artery thrombosis associated with lupus anticoagulant. Surgery. 1985;98:612–5.PubMedGoogle Scholar
  6. 6.
    Li GC, Greenberg CS, Currie MS. Procainamide-induced lupus anticoagulant and thrombosis. South Med J. 1988;81:262–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Asherson RA, Chan JK, Harris EN, Gharavi AE, Hughes GR. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis. 1985;44:823–5.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Hirsh DR, Mikkola KM, Marks PW, et al. PE and DVT during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J. 1996;131:1145–8.CrossRefGoogle Scholar
  11. 11.
    Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V mutation. Ann Intern Med. 1997;126:528–31.CrossRefPubMedGoogle Scholar
  12. 12.
    Cushman M, Rosendaal FR, Psaty BM, Factor V. Leiden is not a risk factor for arterial vascular disease in the elderly: result from the cardiovascular health study. Thromb Haemost. 1998;79:912–5.PubMedGoogle Scholar
  13. 13.
    Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S–75S.CrossRefPubMedGoogle Scholar
  14. 14.
    Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1988;208:227–40.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Nicolaides AN, Miles C, Hoare M, Jury P, Helmis E, Venniker R. Intermittent sequential pneumatic compression of the legs and thromboembolism-deterrent stockings in the prevention of postoperative deep venous thrombosis. Surgery. 1983;94:21–5.PubMedGoogle Scholar
  17. 17.
    Hoek JA, Nurmohamed MT, Hamelynck KJ, et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost. 1992;67:28–32.PubMedGoogle Scholar
  18. 18.
    Turpie AG, Levine MN, Hirsh J, et al. A randomized controlled trial of low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Waring WP, Karunas RS. Acute spinal cord injuries and the incidence of clinically occurring thromboembolic disease. Paraplegia. 1991;29:8–16.PubMedGoogle Scholar
  21. 21.
    Myllynen P, Kammonen M, Rokkanen P, Bostman O, Lalla M, Laasonen E. Deep venous thrombosis and pulmonary embolism in patients with acute spinal cord injury: a comparison with nonparalysed patients immobilized due to spinal fractures. J Trauma. 1985;25:541–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Warkentin TE. Heparin-induced thrombocytopenia: a ten-year retrospective. Ann Rev Med. 1999;50:129.CrossRefPubMedGoogle Scholar
  23. 23.
    Magnani HN. Heparin induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost. 1993;70:554.PubMedGoogle Scholar
  24. 24.
    Greinacher A, Janssens U, Berg G, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation. 1999;100:587–93.CrossRefPubMedGoogle Scholar
  25. 25.
    Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters: indications, safety, effectiveness. Arch Intern Med. 1992;152:1985–94.CrossRefPubMedGoogle Scholar
  27. 27.
    Duckert F, Muller G, Nyman D, et al. Treatment of deep vein thrombosis with streptokinase. BMJ. 1975;1:479–81.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Fahad S. Alasfar
    • 1
  • Dwayne Badgett
    • 1
  • Anthony J. Comerota
    • 1
  1. 1.Department of SurgeryTemple University HospitalPhiladelphiaUSA

Personalised recommendations